2015
DOI: 10.2147/imcrj.s82792
|View full text |Cite
|
Sign up to set email alerts
|

Skull base metastasis from papillary thyroid carcinoma: a report of three cases

Abstract: Skull base metastasis from differentiated thyroid carcinoma, including papillary and follicular thyroid carcinoma, is a rare manifestation. Herein, we present three cases of skull base metastasis of papillary thyroid carcinoma. The mean age of the patients was 68.6 (65–74) years, and the mean interval between initial diagnosis and skull base metastasis was 56.3 (28–89) months. Cranial nerve palsies were seen in all patients. Intensity modulated radiation therapy to deliver 6,000–6,600 cGy to the skull base met… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 14 publications
0
9
0
Order By: Relevance
“…Skull base metastasis from DTC is a rare manifestation with only 28 reported cases, including 18 cases from follicular thyroid carcinoma (FTC) and 10 cases from PTC [18] Diagnosis in the presence of silent primary sites is challenging, because these lesions are often mistaken for primary tumours like meningioma, or schwannoma on CT and magnetic resonance imaging. [19] Histopathology along with immunohistochemical examination is crucial in diagnosing metastasis from DTC. In routine practice, thyroglobulin (TGB) and thyroid transcription factor-1 (TTF1) are the most commonly used immunomarkers to identify thyroid tumors in the setting of metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Skull base metastasis from DTC is a rare manifestation with only 28 reported cases, including 18 cases from follicular thyroid carcinoma (FTC) and 10 cases from PTC [18] Diagnosis in the presence of silent primary sites is challenging, because these lesions are often mistaken for primary tumours like meningioma, or schwannoma on CT and magnetic resonance imaging. [19] Histopathology along with immunohistochemical examination is crucial in diagnosing metastasis from DTC. In routine practice, thyroglobulin (TGB) and thyroid transcription factor-1 (TTF1) are the most commonly used immunomarkers to identify thyroid tumors in the setting of metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…OCS due to thyroid cancer has been previously described. [7] The treatment of OCS is challenging. Complete surgical resection is often difficult because of the presence of adjacent vital structures (brainstem, cochlea, and cranial nerves), cerebrospinal fluid leak, and bleeding.…”
Section: Discussionmentioning
confidence: 99%
“…Thyroid papillary carcinoma gives frequent neck lymph node metastases, occasionally to lung and bones and rarely to other areas (skeletal muscles, ovaries, submandibular gland, sphenoidal sinus, pancreas, brain, adrenal glands) [11]. Previous case reports include also metastatic PTC in infratemporal fossa, pleural metastasis of thyroid carcinoma, skull base metastasis of PTC and PTC with synchronous asymptomatic esophageal squamous cell carcinoma (ESCC) manifesting as lateral cervical lymph node enlargement [12]. Cervical lymphadenopathy as a manifestation of sarcoidosis, mimicking metastatic PTC, has also been reported [13].…”
Section: Discussionmentioning
confidence: 99%